CARLSBAD, Calif.–(BUSINESS WIRE)–Jun. 24, 2026– Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that the U.S. Food and Drug Administration (FDA) has approved TRYNGOLZA® (olezarsen) as an adjunct to diet to reduce triglycerides (TG) and the risk of acute pancreatitis in adults with severe hypertriglyceridemia (sHTG: TG […]

[BOULDER, Colo] — The National Triglyceride Alliance (NTA) proudly marks its one-year anniversary this month, coinciding with National Triglycerides Day on March 28, a national observance dedicated to raising awareness about triglycerides and their role in cardiovascular and metabolic health. Together, these milestones highlight a year […]

Supported by Ionis Pharmaceuticals, Arrowhead Pharmaceuticals, Amarin Corp, and Alliance Partners with Leading Medical Associations [Boulder, CO] – The National Triglyceride Alliance (NTA) is proud to announce its official launch, marking a pivotal step in advancing education and awareness about the critical role of triglycerides in […]